The separation and characterization of fluorescein-labeled polyethylene glycols (PEG) is described. Firstly, the polyethylene glycols labeled with fluorescein isothiocyanate (FITC) were synthesized and separated using Sephadextrade mark LH-20 medium by a step gradient. Secondly, a TSK GEL G4000 PW XL column was developed for determining the FITC derivatives of PEG. The retention mechanism is based on the hydrophobic interaction between the FITC derivatives of PEG and the packing material of the TSK GEL G4000PW XL column. The retention time of the PEG compounds increased by adding of salts in the mobile phase and decreased by adding of organic modifier. In addition, various salts in the eluent can also change the chromatographic behavior of these compounds. Finally, the pH of the mobile phase can have an impact on the retention time of the PEG compounds.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.chroma.2006.06.088 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficiency of Polyethylene Terephthalate Glycol Thermoplastic Material to Functional and Expansion Forces in Orthodontic Applications: An Experimental Study.
ScientificWorldJournal
January 2025
Department of Orthodontics, College of Dentistry, University of Baghdad, Baghdad, Iraq.
While polyethylene terephthalate glycol (PETG) is widely used in orthodontic appliances such as clear aligners and retainers, there is limited experimental data assessing its performance under functional stresses, such as those encountered during dental movements and palatal expansion. This study aims to evaluate the ability of PETG thermoplastic material to withstand deformation under functional and expansion forces, specifically within the context of orthodontic applications. To estimate the firmness of the screw within the appliance, a universal Instron testing machine was used to record the forces released by each activation of the expander within the upper part of 10 clear modified twin blocks (MTBs) made from PETG and compare it with that released by 10 conventional twin blocks (CTBs).
View Article and Find Full Text PDFC-X-C chemokine receptor type 5CD8 T cells as immune regulators in hepatitis Be antigen-positive chronic hepatitis B under interferon-alpha treatment.
World J Gastroenterol
January 2025
Institute of Hepatology and Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China.
Background: C-X-C chemokine receptor type 5 (CXCR5)CD8 T cells represent a unique immune subset with dual roles, functioning as cytotoxic cells in persistent viral infections while promoting B cell responses. Despite their importance, the specific role of CXCR5CD8 T cells in chronic hepatitis B (CHB), particularly during interferon-alpha (IFN-α) treatment, is not fully understood. This study aims to elucidate the relationship between CXCR5CD8 T cells and sustained serologic response (SR) in patients undergoing 48 weeks of pegylated IFN-α (peg-IFN-α) treatment for CHB.
View Article and Find Full Text PDFA multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast cancer.
J Cancer Res Clin Oncol
January 2025
Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Purpose: The primary objectives of this trial were aimed at exploring the pharmacokinetic profiles and the human bioequivalence of an intravenous liposomal injection of doxorubicin hydrochloride in comparison with a reference formulation in Chinese patients diagnosed with metastatic breast cancer.
Methods: To achieve these goals, the trial employed a randomized, open-label, two-formulation crossover dosing strategy among Chinese patients with metastatic breast cancer. Pharmacokinetic (PK) evaluation was conducted through the collection of blood samples, and the liquid chromatography tandem mass spectrometry (LC/MS/MS) method was leveraged to quantify plasma concentrations of both liposome-encapsulated doxorubicin and non-encapsulated doxorubicin in patients.
Hydrogel loaded with cerium-manganese nanoparticles and nerve growth factor enhances spinal cord injury repair by modulating immune microenvironment and promoting neuronal regeneration.
J Nanobiotechnology
January 2025
Department of Orthopedics, Huashan Hospital, Fudan University, No. 12, Middle Wulumuqi Road, Jing'an District, Shanghai, 200040, China.
Background: Spinal cord injury (SCI) treatment remains a formidable challenge, as current therapeutic approaches provide only marginal relief and fail to reverse the underlying tissue damage. This study aims to develop a novel composite material combining enzymatic nanoparticles and nerve growth factor (NGF) to modulate the immune microenvironment and enhance SCI repair.
Methods: CeMn nanoparticles (NP) and CeMn NP-polyethylene glycol (PEG) nanozymes were synthesized via sol-gel reaction and DSPE-mPEG modification.
Biomechanical comparison of the efficacy of Cfr-PEEK and titanium systems in the fixation following sagittal split advancement osteotomy: a biomechanical study.
BMC Oral Health
January 2025
Department of Oral and Maxillofacial Surgery, Ordu University, Cumhuriyet Yerleşkesi Cumhuriyet Mahallesi, 52200, Ordu, Türkiye, Turkey.
Background: This study evaluates the efficacy of carbon fiber reinforced Polyetheretherketone (Cfr-PEEK) in fixation after sagittal split ramus osteotomy (SSRO) by comparing it with titanium in vitro.
Methods: Twenty-eight sheep hemimandibles were randomly assigned to four groups for SSRO surgery. Fixation was performed with a 4-hole titanium mini plate for 5 mm advancement in Group 1, with a 4-hole Cfr-PEEK mini plate for 5 mm advancement for Group 2, with a 4-hole titanium mini plate for 10 mm advancement for Group 3, and with a 4-hole Cfr-PEEK mini plate for 10 mm advancement for Group 4.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!